 Assenagon Asset Management S.A. bought a new position in Ionis Pharmaceuticals Inc NASDAQ:IONS during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission SEC. The institutional investor bought 3,748 shares of the companys stock, valued at approximately 221,000. A number of other institutional investors also recently ... 